Akèy › Limfòm Non-Hodgkin › Kalifòni › Baldwin Park
Etid klinik pou Limfòm Non-Hodgkin nan Baldwin Park, CA
19 etid pou Limfòm Non-Hodgkin ap chèche patisipan nan sit nan ak bò kote Baldwin Park (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Ap rekriteFaz 1/2
- Research Site, Duarte · 4 mi lwen
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
Ap rekriteFaz 1/2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Ap rekriteFaz 2
- Research Site, Duarte · 4 mi lwen
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Ap rekriteFaz 2
- City of Hope Comprehensive Cancer Cente, Duarte · 4 mi lwen
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Ap rekriteFaz 1/2
- City of Hope, Duarte · 4 mi lwen
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Ap rekriteFaz 1Volontè an sante akeyi
- City of Hope Medical Center, Duarte · 4 mi lwen
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- City of Hope, Duarte · 4 mi lwen
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Ap rekriteFaz 1/2
- City of Hope, Duarte · 4 mi lwen
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
Ap rekriteFaz 2
- City of Hope National Medical Center, Duarte · 4 mi lwen
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Ap rekriteFaz 2Volontè an sante akeyi
- City of Hope Medical Center, Duarte · 4 mi lwen
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Duarte · 4 mi lwen
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Ap rekriteEtid obsèvasyon
- City of Hope, Duarte · 4 mi lwen
Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
Etid Limfòm Non-Hodgkin nan lòt vil
- New York City, NY31 etid
- Houston, TX31 etid
- Boston, MA26 etid
- Nashville, TN21 etid
- Philadelphia, PA20 etid
- Washington, DC18 etid
- Chicago, IL18 etid
- Milwaukee, WI18 etid
- Atlanta, GA18 etid
- Columbus, OH18 etid
- Dallas, TX17 etid
- Seattle, WA16 etid
Lòt etid nan Baldwin Park
- Kansè nan tete44 etid
- Leksemi mieloïd egi40 etid
- Kansè kolorektal37 etid
- Kansè Poumon ki pa ti selil36 etid
- Kansè (tout kalite)34 etid
- Kansè pwostat30 etid
- Kansè Metastatik30 etid
- Sendwòm myelodisplastik26 etid
- Kansè ovè25 etid
- Kansè poumon24 etid
- Myelom Miltip23 etid
- Kansè lestomak22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.